sufentanil
Drug ingredientActive ShortageThis drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
Where It Comes From
4 FDA-registered drug labelers
AcelRx Pharmaceuticals, Inc.
Patheon Pharmaceuticals Inc.
SpecGx LLC
Veranova, L.P.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Dsuvia
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
Active Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
current
Sufentanil Citrate Injection
05/03/2022Unavailable
current
Sufentanil Citrate Injection
05/03/2022Available
Chemical Identity
CAS56030-54-7
PubChem CID41693
DTXSIDDTXSID6023604
FormulaC22H30N2O2S
Mol. Weight386.6 g/mol
SMILESCCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
Data Sources
416932026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/sufentanil/cids/JSON
Archive: data/sources/pubchem_name/sufentanil.json
CAS 56030-54-72026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 56030-54-72026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json